Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial.
暂无分享,去创建一个
W. Weaver | C. Grines | R. Becker | R. Harrington | J. Bittl | D. Kereiakes | H. Emanuelsson | I. Gilchrist | A. Greenbaum | D. Grogan | J. Stankowski | Jane Clegg | D. Grogan | Jill Stankowski